Syneron Medical Ltd (ELOS) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Syneron Medical Reports Record Fourth Quarter 2015 Revenue of $78.9 Million
February 22, 2016 7:00 AM ESTIRVINE, Calif., Feb. 22, 2016 /PRNewswire/ --Â Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three and twelve month periods ended December 31, 2015.
Fourth Quarter 2015 and Recent Non-GAAP[1] Highlights:
Record revenue of $78.9 million, compared to $74.1 million in the fourth quarter 2014, up 7% year-over-year, or 11% in constant currency North American product sales grew 23% year-over-year Total Body Shaping revenue of $9.3 million, including North America UltraShape® revenue of $5.2 million;... More